4AB:FRA
AbbVie Common Stock
€262.80
arrow_upward
+1.04%(+2.70) 1D
Nov 20, 10:00:00 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
€259.20
High
€262.80
Low
€258.60
Mkt. cap
505.89B
Avg. vol.
101.00
Volume
75.00
52-wk high
€272.30
52-wk low
€167.55
No. of employees
57K
Open
€259.20
High
€262.80
Low
€258.60
Mkt. cap
505.89B
Avg. vol.
101.00
Volume
75.00
52-wk high
€272.30
52-wk low
€167.55
No. of employees
57K
News stories
From web sources and news partners
The Motley Fool
·
2 hours ago
AbbVie (ABBV) Stock Just Got a 5.2% Dividend Increase. Here's How Many Shares You Need to Generate $1,000 a Year.
ad-hoc-news.de
·
6 hours ago
AbbVie stock: Piper Sandler raises target to USD 349
Yahoo Finance
·
15 hours ago
Is Solid Tumor Partnership Altering The Investment Case For AbbVie (ABBV)?
The Motley Fool
·
23 hours ago
AbbVie vs. Eli Lilly: Which Healthcare Stock Is a Better Buy for 2027?
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorHealth Care
IndustryBiotechnology
Websiteabbvie.com